On this page, you can find the information that we believe is both interesting and relevant to existing and potential investors in Audientes.

It includes company announcements, press releases, and our financial calendar, to ensure that you don’t miss out on any important news regarding the Audientes share.

Join us on our journey to make smart, self-fitting and affordable hearing aids available to the millions of people around the world suffering from disabling hearing loss.

Watch the video to learn more.

Company announcements

Leadership

Steen Thygesen

CEO

Steen has a bachelor degree in Electronics Engineering from Copenhagen’s Teknikum, and an MBA from London Business School. Throughout his 30-year career, both abroad and in Denmark, he has held positions at Star, Nokia Denmark A/S, Microsoft Inc., Symbian PLC, Psion Software PLC, CompuServe Inc. and TDC. He was also the Managing Director of Specialisterne Foundation, owner of the social economic enterprise, Specialisterne, where he led the establishment and growth of Specialisterne in 15 countries.

Hossein Jelveh

CTO

Hossein has an MA in Electric Engineering from Danmark’s Tekniske University. He began his career in Nokia in 1997 as a software engineer and held a number of roles, including Test Manager. In 2012, he founded the hearing aid research and development company, Jelveh Medical Device. In 2014, he founded Audientes.

Board of directors

Povl-André Bendz

Board Chairperson

Povl-André has a Masters of Science from CBS, and a long career in the life sciences industry, where he held several commercial and financial leadership positions. He holds a number of board positions, including Chairman of the Board for 2cureX AB, which is listed on the Nasdaq First North Sweden exchange.

Gitte Jürgens

Board member

Gitte has a degree in market economies and has more than 20 years of leadership experience within life sciences industries and has worked with strategic and commercial business development. She has held positions that include CFO, COO as well as Supply Chain Manager in pharmaceutical companies, Meda and Mylan. In connection with these, she has participated in several international M&A transactions. She currently holds the CEO position at UV Clinical.

Elsebeth Finnick

Board member

Elsebeth has a university degree in Economics and has held numerous international positions within the life sciences industry, including international manager in GN Danavox A/S (now GN Resound), Director at Coloplast A/S as well as CEO of Danish Health Consult A/S. Additionally, she has been the Dean of the Bioanalyst Faculty in Copenhagen and Mentor at DTU Science Park, DeepTech mentoring since 2014.

Financial and legal documents

Legal documentation

Financial calendar

Date Event
October 22, 2020 Q3 2020 reporting
March 18, 2021 Q4 and Annual Report 2020
April 13, 2021 Annual General Meeting 2021
May 20, 2021 Q1 2021 reporting
August 19, 2021 Q2 2021 reporting
November 18, 2021 Q3 2021 reporting

Certified advisor

logo_sort_gul

www.kapitalpartner.dk

Jernbanegade 4, 1608 København

+ 45 89 88 78 46

Start typing and press Enter to search

Shopping Cart